Ninety outpatients treated for the first time with i.v. CMF were included in a study aimed at the efficacy and safety of low doses of Alizapride (ALZ) versus equal doses of Metoclopramide (MCP) and Placebo (P)....
Alizapride versus metoclopramide versus placebo in the treatment of CMF-induced emesis in breast cancer patients
STEFANATI, Armando;MALACARNE, Paolo
1990
Abstract
Ninety outpatients treated for the first time with i.v. CMF were included in a study aimed at the efficacy and safety of low doses of Alizapride (ALZ) versus equal doses of Metoclopramide (MCP) and Placebo (P)....File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
